Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.

Castellucci LA, Chen VM, Kovacs MJ, Lazo-Langner A, Greenstreet P, Kahn S, Côté B, Schulman S, de Wit K, Douketis J, Suryanarayan D, Wan T, Yeo E, Le Templier G, Tran HA, Willcox A, Crowther HJ, Prasad R, Shivakumar S, Umana E, Ni Ainle F, Tritschler T, Barco S, Galanaud JP, Blondon M, Baumann Kreuziger L, Solymoss S, Kearon C, Thomas E, Ramsay T, Le Gal G, Rodger M, COBRRA Trial Investigators

Open source

DOI: 10.1056/nejmoa2510703
Published: 2026 Mar 12
Container: The New England journal of medicine
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2510703,
  title = {Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.},
  author = {Castellucci LA and Chen VM and Kovacs MJ and Lazo-Langner A and Greenstreet P and Kahn S and Côté B and Schulman S and de Wit K and Douketis J and Suryanarayan D and Wan T and Yeo E and Le Templier G and Tran HA and Willcox A and Crowther HJ and Prasad R and Shivakumar S and Umana E and Ni Ainle F and Tritschler T and Barco S and Galanaud JP and Blondon M and Baumann Kreuziger L and Solymoss S and Kearon C and Thomas E and Ramsay T and Le Gal G and Rodger M and COBRRA Trial Investigators},
  year = {2026},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa2510703},
  url = {https://doi.org/10.1056/nejmoa2510703}
}

RIS

TY  - JOUR
TI  - Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.
AU  - Castellucci LA
AU  - Chen VM
AU  - Kovacs MJ
AU  - Lazo-Langner A
AU  - Greenstreet P
AU  - Kahn S
AU  - Côté B
AU  - Schulman S
AU  - de Wit K
AU  - Douketis J
AU  - Suryanarayan D
AU  - Wan T
AU  - Yeo E
AU  - Le Templier G
AU  - Tran HA
AU  - Willcox A
AU  - Crowther HJ
AU  - Prasad R
AU  - Shivakumar S
AU  - Umana E
AU  - Ni Ainle F
AU  - Tritschler T
AU  - Barco S
AU  - Galanaud JP
AU  - Blondon M
AU  - Baumann Kreuziger L
AU  - Solymoss S
AU  - Kearon C
AU  - Thomas E
AU  - Ramsay T
AU  - Le Gal G
AU  - Rodger M
AU  - COBRRA Trial Investigators
PY  - 2026
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa2510703
UR  - https://doi.org/10.1056/nejmoa2510703
ER  -

APA

LA, C., VM, C., MJ, K., A, L., P, G., S, K., B, C., S, S., K, D. W., J, D., D, S., T, W., E, Y., G, L. T., HA, T., A, W., HJ, C., R, P., S, S., E, U., F, N. A., T, T., S, B., JP, G., M, B., L, B. K., S, S., C, K., E, T., T, R., G, L. G., M, R., & Investigators, C. T. (2026). Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.. The New England journal of medicine. https://doi.org/10.1056/nejmoa2510703

Source records

pubmed · retrieved 2026-09-25T10:45:05.342Z
europe-pmc · retrieved 2026-09-25T10:45:05.334Z